Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, considered and approved the appointment of Tapas Guha Thakurata as the Chief Executive Officer (CEO) of the Company– Key Managerial Personnel under the provisions of the Companies Act, 2013 and rules there under. The company has annexed the disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 relating to appointment of Tapas Guha Thakurata as the CEO (Annexure I). The company has commenced from 10:30 am and concluded on 10:48 am.
The above information is a part of company’s filings submitted to BSE.
